Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 837 of 1,261

  1. US 8613900

    Nanostructured transition metal oxides useful for water oxidation catalysis

    The Regents of the University of California · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  2. US 8614301

    Methods of treating cancer using anti CD24 antibodies

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  3. US 8614189

    Carbon nanotube composite scaffolds for bone tissue engineering

    UNIVERSITY OF CONNECTICUT · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  4. US 8614208

    Fused heterocyclic ring derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  5. US 8614252

    Crystalline solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  6. US 8613905

    Diagnostic agent

    UNITED ARAB EMIRATES UNIVERSITY · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  7. US 8613932

    GP100-specific T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  8. US 8613933

    Brachyury polypeptides and methods for use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  9. US 8613934

    Cellular and viral inactivation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  10. US 8613944

    Compositions and methods for separating tissue

    The Board of Regents of the University of Texas System · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  11. US 8613963

    Nutritional supplement

    Healthy Drink Discoveries Incorporated · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  12. US 8614082

    Attenuation of encephalitogenic alphavirus and uses thereof

    The Board of Regents of the University of Texas System · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  13. US 8614198

    Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use

    Alnylam Pharmaceuticals, Inc. · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  14. US 8614183

    Use of FGFR1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in FGFR2

    Five Prime Therapeutics, Inc. · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  15. US 8614325

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  16. US 8613904

    Methods for diagnosis and intervention of hepatic disorders

    The Regents of the University of Colorado · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  17. US 8609162

    Integrated neuromodulation system for mood enhancement of a living human subject

    InVivo Beverages LLC · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  18. US 8609102

    Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of ISAA or ISAB

    Julius-Maximilians-Universitaet · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  19. US 8609608

    Antimicrobial peptides

    The Regents of the University of California · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  20. US 8609648

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  21. US 8609417

    Methods and compositions for stem cell cultures

    The Regents of the University of California · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  22. US 8609412

    Mapc generation of lung tissue

    Regents of the University of Minnesota · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  23. US 8609404

    Vaccines containing canine parvovirus genetic variants

    The Board of Regents for Oklahoma State University · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  24. US 8609395

    Agonist and antagonist peptides of carcinoembryonic antigen (CEA)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.